HIV drug resistance: brief report 2024
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment. In this report, WHO documents
Drugs
-
Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016
<p>Millions of people, particularly in low- and middle-income countries, lack access to effective pharmaceuticals, often because they are unaffordable. The 2001 Ministerial Conference of the World Trade
-
Malawi is first African nation using new WHO approved typhoid vaccine
Malawi has launched a new generation of typhoid vaccines making it the first country in Africa using the vaccines to fight typhoid infections in children. Four-year-old Golden Kondowe was the first
-
An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: Implications to a novel combinatorial therapy
<p>The existing treatment regime against tuberculosis is not adequate, and novel therapeutic interventions are required to target Mycobacterium tuberculosis (Mtb) pathogenesis. We report Pranlukast (PRK)
-
New drug targets for malaria found
Scientists have discovered crucial new processes that allow malaria parasites to escape red blood cells and infect other cells, offering potential new treatment targets. The researchers are working with
-
Private hospitals making profits of up to 1,737% on drugs, consumables and diagnostics: Study
NEW DELHI: An analysis of bills from four reputed private hospitals in Delhi and NCR by the National Pharmaceutical Pricing Authority (NPPA) has revealed that they are making profits of up to 1,737% on
-
Pyrogenium no dengue preventive medicine
Experts seek action against entity distributing drug in schools. Hyderabad: A private organisation, Telangana Public Health Council, is conducting dengue fever awareness campaign in city schools in
-
Kenya plans new regulatory framework for alternative medicine
Kenya has formed a task force to develop regulatory framework toward the adoption of alternative medicine in the mainstream medical sector, a government official said on Wednesday. Sicily Kariuki, Cabinet
-
64% of antibiotics sold in India unapproved: UK study
Multinational companies continue to produce and sell unregulated antibiotics in India, worsening the problem of antimicrobial resistance in the country and impeding efforts to fight drug resistance globally,
-
Research claims lack of access to essential medicines in India
A research study claims that Indians lack access to essential medicines despite the government approving thousands of drugs to ensure their wider availability. The study has been jointly conducted by
-
UP hails Rs 600 crore for nutritional support to TB patients
Meerut: In an attempt to achieve its goal of eliminating tuberculosis, Union finance minister Arun Jaitley in his budget speech on Thursday allocated Rs 600 crore for nutritional support to TB patients